Opinion: We need resilient healthcare supply chains for the next time

Over the past two and a half years, we have seen unparalleled innovation and private-public collaboration in the global fight against Covid-19. The rapid development and roll-out of new vaccines, diagnostic tests and therapeutics have saved millions of lives.

However, these developments have not benefited everyone equally. Although more than 67 per cent of the global population has received at least one dose of the Covid-19 vaccine, disparities between the higher and lower income countries are wide. As of this month, 72 per cent of people in high-income countries have received one dose, compared to 18 per cent in low-income countries, according to the United Nation’s Development Programme’s Global Dashboard for Vaccine Equity.

Read the full article

Previous
Previous

OECD Health Systems Resilience Webinar

Next
Next

Physicians, nurses offer solutions to immediately address health human resource crisis